myBMI

Provider Profile Name: myBMI
Website: my-bmi.co.uk
Provider Type: UK-Based Online Weight Management Clinic — Pharmacist-Led
Regulatory Framework: UK — General Pharmaceutical Council (GPhC)

Operating Details

• UK-regulated online clinic focused entirely on weight loss; prescribes brand-name GLP-1s Wegovy and Mounjaro through a licensed UK pharmacy
• Partners with Chemist4U, a GPhC-registered UK pharmacy, for all prescription fulfillment and medication dispensing
• Pharmacist-led prescribing rather than physician-led — prescribers are weight management specialist pharmacists
• Nutrition guidance, mental health resources, and access to the myBMI Community included at no extra cost
• No insurance accepted; no long-term commitment; monthly renewal model
• Pricing in GBP (£)

Approach myBMI runs on a simple principle: safe, structured treatment guided by specialists. Every step is designed to check your health, prescribe the right GLP-1, and adjust it responsibly — on a 28-day cycle so progress and side effects are never ignored. Unlike most platforms reviewed in this series, myBMI operates entirely within the UK regulatory framework and is not a compounding-based platform — it prescribes only licensed, brand-name GLP-1 medications approved by UK regulators.

About the Company

myBMI’s clinical model is pharmacist-led rather than physician-led — a structural difference from all other platforms in this review series. Care comes from prescribing pharmacists who specialize in weight management rather than medical doctors. Pharmacists in the UK can hold independent prescribing qualifications, making this a legitimate and regulated pathway — but one that differs meaningfully from the physician-supervised models typical in US telehealth GLP-1 programs.

The so-called follow-ups offered through myBMI’s service are not full face-to-face consultations with a provider but brief check-ins designed to review progress and adjust plans if needed, offering far less opportunity for meaningful medical oversight since providers are not fully evaluating the patient or catching issues that might emerge in a real clinical conversation.

Unlike some telehealth clinics, myBMI does not routinely require lab work before prescribing GLP-1 medications — allowing for faster onboarding but removing an important safety checkpoint. Patients with comorbidities such as thyroid conditions, diabetes, or kidney disease should discuss lab requirements directly with a myBMI prescriber before beginning treatment.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

The platform operates on NHS-adjacent framing: patients can access treatment through myBMI without the lengthy delays often associated with NHS weight management pathways, while still receiving safe, regulated and clinically supervised care. This positions myBMI as a private-pay alternative for UK patients who meet eligibility criteria but face long NHS waitlists.

GLP-1 Offerings and Weight Loss Services

myBMI prescribes brand-name GLP-1 medications only. No compounded semaglutide or tirzepatide is available.

Weekly Injectables:

• Wegovy (semaglutide) — FDA-approved equivalent for weight loss in the US; licensed for weight management in the UK
• Mounjaro (tirzepatide) — UK brand name for the dual GIP/GLP-1 agonist (equivalent to Zepbound in the US for weight management)

Oral Formats:

• Daily oral tablet formats are mentioned on the myBMI site, though they are not listed in active treatment plans; orforglipron, a once-daily oral GLP-1, is shown as “coming soon”

Side Effect Management (included):

• Medications for managing side effects include macrogol, omeprazole, loperamide, lansoprazole, Gaviscon mint chewable tablets, and prochlorperazine

Additional Support (included):

• Nutrition guidance, mental health resources, and access to the myBMI Community at no extra cost

Pricing — and What Reviewers Say

myBMI keeps its pricing simple to follow, though not flat. Patients pay for a 28-day treatment plan that includes consultation, prescription, and medication — with no separate membership or subscription fee. Prices increase as the GLP-1 dose rises, which is standard for brand-name injectables like Wegovy and Mounjaro. All pricing is in GBP and not directly comparable to USD-denominated US platforms.

myBMI does not accept insurance, and there is no long-term commitment — patients renew monthly after completing a short check-in and can cancel any time before the next order ships.

What reviewers say about pricing: Some reviewers note that costs have increased over time, with at least one patient reporting they could obtain their injection pen at a lower price through alternative providers — a recurring concern in the UK’s increasingly competitive private GLP-1 market, where pricing pressure has intensified as more pharmacies and online clinics enter the space.

Reviews from Trustpilot and Google

myBMI has 1,264 Trustpilot reviews at time of writing on the UK Trustpilot platform — a meaningful pool for a UK-focused clinic.

What patients praise:

• Fast delivery — multiple reviewers praise prescription approval and delivery within 48 hours
• Clinical review process — patients appreciate that each case is reviewed by a professional before each refill, with several noting the prescriber checked existing medications for interactions and informed their GP of the treatment
• Reliable access during periods of Mounjaro shortage when other providers ran out of stock

Common complaints:

• At least one reviewer describes the monthly medicine review for Wegovy titration as a “tick box” exercise with little genuine clinical evaluation — a concern that aligns with the brief check-in format rather than full consultation model
• Price increases over time noted as a friction point for long-term patients
• Limited lifestyle support and no app compared to more comprehensive platforms

Compounding Pharmacies Used

myBMI does not use compounding pharmacies. All prescriptions are filled and shipped by Chemist4U, a GPhC-registered UK pharmacy — dispensing licensed, brand-name Wegovy and Mounjaro pens directly to patients. This entirely eliminates the compounding quality, potency, and sourcing concerns present in most of this review series, as every medication shipped is a manufacturer-produced, regulatory-approved finished product.

Note: myBMI is a UK-only provider. Its website (my-bmi.co.uk) operates under UK regulatory authority (GPhC), prices are in GBP, and it dispenses through a UK-registered pharmacy. It is not licensed to serve US patients and cannot prescribe to or ship medication to addresses in the United States. US-based readers looking for weight loss telehealth services should refer to other providers in this directory. myBMI appears in this review series because it is listed in the weightlossinjections.com directory, which includes international providers alongside US-based platforms.